Logo

People in the News: Bruker, Waters

May 17, 2013
Premium

Bruker's shareholders have re-elected its class 1 directors to serve until the company's 2016 shareholder meeting, including Wolf-Dieter Emmerich; Brenda Furlong; Frank Laukien; and Richard Packer.

Waters' shareholders have re-elected the firm's board of directors, including Douglas Bethiaume; Joshua Bekenstein; Michael Berendt; Edward Conrad; Laurie Glimcher; Christopher Kuebler; William Miller; JoAnn Reed; and Thomas Salice.

Filed under

Proteomics & Protein Research
Waters
proteomics
Bruker
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.